CCND1 and cancer: As traditional cancer epidemiology-approaches have not generally taken clinicopathological and key molecular characteristics, e.g. expression of beta-catenin, cyclin D1, p53 and mismatch repair proteins [10-13] into account, the impact of hormonal factors on CRC risk may be further clarified by doing so [14].